Recent Updates
Recently added Catalysts
PTCT Positive Sentiment

PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Key Takeaway: PTC Therapeutics, Inc. will hold a webcast conference call on July 30, 2026, to report its second quarter financial results and discuss its business outlook. The event will be accessible via the company's website, with a replay available for 30 days. PTC focuses on developing treatments for rare disorders.
Price reaction · baseline $78.84 (2026-07-15 close) · hit pre-market · clean, no other PTCT news in the window
day 0 close
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is actively engaging with investors through a conference call.
  • The company is committed to providing updates on its business and financial performance.
  • PTC has a diversified pipeline aimed at addressing rare disorders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

WARREN, N.J.,July 16, 2026/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the company will host a webcast conference call to report its second quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, July 30, 2026, at 4:30 p.m. ET.
To access the live webcast, please visit the "Events & Presentations" page within the Investors section of thePTC website. A replay of the webcast will be available on the PTC website for 30 days following the event. To participate via phone, please register in advancehereto receive dial-in details.
About PTC Therapeutics, Inc.PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visitwww.ptcbio.comand follow us on LinkedIn, X, Facebook and Instagram.

Investors:Ellen Cavaleri+1 (615) 618-8228[email protected]

Media:Jeanine Clemente+1 (908) 912-9406[email protected]

Frequently Asked Questions

When will PTC Therapeutics report its Q2 2026 results?

PTC Therapeutics will report its Q2 2026 financial results on July 30, 2026.

How can I access the PTC Therapeutics webcast?

The webcast can be accessed via the 'Events & Presentations' page on the PTC website.

Will there be a replay of the webcast?

Yes, a replay of the webcast will be available for 30 days after the event.

What is PTC Therapeutics focused on?

PTC Therapeutics is focused on developing treatments for rare disorders.

Last updated: Jul 16, 2026